Brief: Egetis Therapeutics H1 Adjusted EPS SEK -0.4
Aug 21 (Reuters) - Egetis Therapeutics H1 net income SEK -140.5 million. H1 revenue SEK 27.1 million
Aug 21 (Reuters) - Egetis Therapeutics H1 net income SEK -140.5 million. H1 revenue SEK 27.1 million